Related references
Note: Only part of the references are listed.Bloodstream Infections due to Carbapenem-ResistantKlebsiella pneumoniae: A Single-Center Retrospective Study on Risk Factors and Therapy Options
Lisha Shen et al.
MICROBIAL DRUG RESISTANCE (2021)
Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review
M. Nguyen et al.
JOURNAL OF APPLIED MICROBIOLOGY (2021)
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy
Nan-Yao Lee et al.
CLINICAL THERAPEUTICS (2020)
Does Antimicrobial Therapy Affect Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria? A Nationwide Multicenter Study in Taiwan
Chien Chuang et al.
MICROORGANISMS (2020)
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
Marco Falcone et al.
CRITICAL CARE (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection
Gregory Saraiva Medeiros et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients
Tingting Xiao et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
Zhe Wang et al.
CHINESE MEDICAL JOURNAL (2018)
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
Matt Shirley
DRUGS (2018)
Clonal dissemination of carbapenemase-producing Klebsiella pneumoniae: Two distinct sub-lineages of Sequence Type 11 carrying blaKPC-2 and blaOXA-48
Min-Chi Lu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections A retrospective cohort study
Ting-Ting Geng et al.
MEDICINE (2018)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Hajo Grundmann et al.
LANCET INFECTIOUS DISEASES (2017)
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
Liangfei Xu et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
Kirk Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
A. Gomez-Simmonds et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Understanding the mechanisms and drivers of antimicrobial resistance
Alison H. Holmes et al.
LANCET (2016)
Use of Platelet Indices for Determining Illness Severity and Predicting Prognosis in Critically Ill Patients
Sheng Zhang et al.
CHINESE MEDICAL JOURNAL (2015)
A review on colistin nephrotoxicity
Atefeh Ordooei Javan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit
Konstantinos Z. Vardakas et al.
JOURNAL OF INFECTION (2015)
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
Marcelino Gonzalez-Padilla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
An Association of Genotypes and Antimicrobial Resistance Patterns among Salmonella Isolates from Pigs and Humans in Taiwan
Hung-Chih Kuo et al.
PLOS ONE (2014)
Tigecycline: an update
Gary E. Stein et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
National Surveillance Study on Carbapenem Non-Susceptible Klebsiella pneumoniae in Taiwan: The Emergence and Rapid Dissemination of KPC-2 Carbapenemase
Sheng-Kang Chiu et al.
PLOS ONE (2013)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
May Nguyen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes
Eleni Mouloudi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units
Joao F. P. Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS: A COMPARISON OF THE PITT BACTEREMIA SCORE AND THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORING SYSTEMS
Ji-Young Rhee et al.
SHOCK (2009)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
